| dbo:abstract |
Mestranol/hydroxyprogesterone acetate (ME/OHPA), sold under the brand name Hormolidin, is a combination medication of mestranol (ME), an estrogen, and hydroxyprogesterone acetate (OHPA), a progestin, which was reportedly used as a sequential combined birth control pill for women in the early 1970s. It was formulated as oral tablets and contained 16 tablets of 80 μg ME, 5 tablets of 80 μg ME and 100 mg OHPA, and 7 placebo tablets (28 tablets in total). The medication was manufactured by the pharmaceutical company Gador in Argentina. (en) |
| dbo:alternativeName |
Hormolidin (en) |
| dbo:class |
dbr:Progestogen dbr:Estrogen_(medication) |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Mestranol.svg?width=300 |
| dbo:wikiPageID |
60999584 (xsd:integer) |
| dbo:wikiPageLength |
2935 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
995970910 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Progestin dbr:List_of_combined_sex-hormonal_preparations dbr:Progestogen dbr:Pharmaceutical_company dbc:Abandoned_drugs dbr:Estrogen_(medication) dbr:Oral_administration dbc:Combined_estrogen–progestogen_formulations dbr:Combination_drug dbr:Hydroxyprogesterone_acetate dbr:Argentina dbr:Tablet_(pharmacy) dbr:Placebo dbr:Mestranol dbr:Combined_birth_control_pill |
| dbp:caption |
dbr:Hydroxyprogesterone_acetate Mestranol and (en) |
| dbp:class |
dbr:Progestogen dbr:Estrogen_(medication) |
| dbp:component |
Hydroxyprogesterone acetate (en) Mestranol (en) |
| dbp:drugName |
Mestranol / (en) hydroxyprogesterone acetate (en) |
| dbp:image |
17 (xsd:integer) |
| dbp:routesOfAdministration |
dbr:Oral_administration |
| dbp:synonyms |
ME/OHPA; EEME/OHPA (en) |
| dbp:tradename |
Hormolidin (en) |
| dbp:type |
combo (en) |
| dbp:width |
250 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Drugbox dbt:Estrogen_receptor_modulators dbt:Genito-urinary-drug-stub dbt:Progesterone_receptor_modulators dbt:Reflist dbt:Estrogens_and_antiestrogens dbt:Progestogens_and_antiprogestogens |
| dct:subject |
dbc:Abandoned_drugs dbc:Combined_estrogen–progestogen_formulations |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:CombinationDrug dbo:Drug |
| rdfs:comment |
Mestranol/hydroxyprogesterone acetate (ME/OHPA), sold under the brand name Hormolidin, is a combination medication of mestranol (ME), an estrogen, and hydroxyprogesterone acetate (OHPA), a progestin, which was reportedly used as a sequential combined birth control pill for women in the early 1970s. It was formulated as oral tablets and contained 16 tablets of 80 μg ME, 5 tablets of 80 μg ME and 100 mg OHPA, and 7 placebo tablets (28 tablets in total). The medication was manufactured by the pharmaceutical company Gador in Argentina. (en) |
| rdfs:label |
Mestranol/hydroxyprogesterone acetate (en) |
| owl:sameAs |
wikidata:Mestranol/hydroxyprogesterone acetate https://global.dbpedia.org/id/9W9YE |
| prov:wasDerivedFrom |
wikipedia-en:Mestranol/hydroxyprogesterone_acetate?oldid=995970910&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Mestranol.svg wiki-commons:Special:FilePath/17-Acetoxyprogesterone.svg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Mestranol/hydroxyprogesterone_acetate |
| foaf:name |
Mestranol / (en) hydroxyprogesterone acetate (en) |
| is dbo:wikiPageRedirects of |
dbr:Hormolidin dbr:Mestranol/Hydroxyprogesterone_acetate dbr:Mestranol/OHPA dbr:Hydroxyprogesterone_acetate/Mestranol dbr:Hydroxyprogesterone_acetate/mestranol dbr:EEME/OHPA dbr:OHPA/EEME dbr:OHPA/ME dbr:OHPA/Mestranol dbr:OHPA/mestranol dbr:ME/OHPA |
| is dbo:wikiPageWikiLink of |
dbr:List_of_combined_sex-hormonal_preparations dbr:Hormolidin dbr:Hydroxyprogesterone_acetate dbr:Mestranol/Hydroxyprogesterone_acetate dbr:Mestranol/OHPA dbr:Hydroxyprogesterone_acetate/Mestranol dbr:Hydroxyprogesterone_acetate/mestranol dbr:EEME/OHPA dbr:OHPA/EEME dbr:OHPA/ME dbr:OHPA/Mestranol dbr:OHPA/mestranol dbr:ME/OHPA |
| is foaf:primaryTopic of |
wikipedia-en:Mestranol/hydroxyprogesterone_acetate |
